Safety and blood-drug study of XFB19 in healthy adults
This Phase 1 study tests whether XFB19 is safe and tolerable in healthy adults and how the drug moves through the body (what the blood levels look like). You would be in the study to help researchers understand early safety and dosing information.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You can sign informed consent and understand the study risks and purpose
- You are 18 to 55 years old and your weight and body size are within set limits
- You have not used tobacco or marijuana (including e-cigarettes) for at least 1 month before dosing
- You are generally healthy, with normal test results for heart rate, blood pressure, temperature, blood/urine tests, and an ECG with acceptable QT timing
- You can provide blood samples and you agree to follow the study schedule and restrictions
- If you can become pregnant or can get a partner pregnant, you must use effective birth control and follow study pregnancy/donation rules
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tracks how a new drug, called FXS4640, moves through the body in healthy men. It uses a small amount of radioactivity to follow the drug, which helps researchers understand how it is absorbed and cleared. Participation involves staying at the clinic for several days for tests and samples.
This early-stage study tests whether a new drug called FB102 is safe in people without serious health conditions. Researchers will monitor volunteers closely to understand how the body handles the drug.
This trial tests a new oral medication, called FB-101, in healthy adult men to see how safe it is and how the body processes it. Participation involves multiple visits and taking the drug in different doses.
This trial tests a new medicine called ADX-001 in healthy adults to see if it is safe, how the body handles it, and whether it triggers an immune response. It is an early-stage study, so it will help determine if the drug is safe enough for further testing in people with certain conditions.
This trial is testing a new study drug called XKH001 in healthy volunteers to see how it affects the body. It is the first time this drug is being studied in people of European descent.
This study tests a new medicine in healthy people to see if it is safe and how the body handles it. Participating could help understand side effects before testing in patients.
Hear when a new Focus of the Study: Safety of XFB19 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.